Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic

類似資料

• COVID‐19 and immunosuppressive therapy in dermatology
  著者:: Schwartz, Robert A., 等
  出版事項: (2020)
• Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina()
  著者:: Zimman, S., 等
  出版事項: (2020)
• The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology
  著者:: Reinholz, Markus, 等
  出版事項: (2021)
• Teledermatology for patient management, dermatology education and research during the COVID‐19 pandemic
  著者:: Cinelli, Eleonora, 等
  出版事項: (2020)
• Considerations for dermatology residency applicants underrepresented in medicine amid the COVID-19 pandemic
  著者:: Jones, Virginia A., 等
  出版事項: (2020)